Richard Cathomas, MD, PhD, Hospital Graubünden, Chur, Switzerland, provides key takeaways in urothelial carcinoma (UC) at this years American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, including results of N-803, an IL-15RαFc superagonist, with BCG in BCG-unresponsive non-muscle invading bladder cancer. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.